Back to 
Brevan Howard Capital Management LP
Brevan Howard Capital Management LP
NTLA
Showing 8 of 11 quarters
Position history for Brevan Howard Capital Management LP's holdings in Intellia Therapeutics, Inc.
Yes. Brevan Howard holds 77,951 shares of NTLA (Intellia Therapeutics), worth $1.3M, as of its Q2 2026 13F filing. It increased the position by 4,028 shares (+5.5%) from Q1 2026. Brevan Howard has held NTLA since Q2 2025, across 5 quarterly 13F filings.
Current Value
$1.3M
Current Shares
77,951
Total Value Change
+$1M
Total Shares Change
+63,033
Quarter-by-Quarter History
Other major holders of NTLA: ARK Investment Management LLC